Glutamate Metabolism is Impaired in Transgenic Mice with Tau Hyperphosphorylation

[1]  Ravinder Reddy,et al.  Imaging of glutamate neurotransmitter alterations in Alzheimer's disease , 2013, NMR in biomedicine.

[2]  M. Witter,et al.  Altered neurochemical profile in the McGill‐R‐Thy1‐APP rat model of Alzheimer's disease: a longitudinal in vivo 1H MRS study , 2012, Journal of neurochemistry.

[3]  F. van Leuven,et al.  Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice , 2011, The Journal of Neuroscience.

[4]  R. Bartha,et al.  Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.

[5]  J. Götz,et al.  Animal models reveal role for tau phosphorylation in human disease. , 2010, Biochimica et biophysica acta.

[6]  C. Jack,et al.  MRS in presymptomatic MAPT mutation carriers , 2010, Neurology.

[7]  R. Gruetter,et al.  Deep thiopental anesthesia alters steady‐state glucose homeostasis but not the neurochemical profile of rat cortex , 2010, Journal of neuroscience research.

[8]  J. Götz,et al.  Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.

[9]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[10]  Naokazu Miyamoto,et al.  Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  J. Götz,et al.  Divergent phosphorylation pattern of tau in P301L tau transgenic mice , 2008, The European journal of neuroscience.

[12]  A. Drzezga,et al.  Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study , 2007, Neurobiology of Aging.

[13]  D. Kondziella,et al.  Glial–Neuronal Interactions are Impaired in the Schizophrenia Model of Repeated MK801 Exposure , 2006, Neuropsychopharmacology.

[14]  A. Schousboe,et al.  The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer , 2006, Journal of neurochemistry.

[15]  J. Götz,et al.  Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? , 2006, Journal of neurochemistry.

[16]  Ger J. A. Ramakers,et al.  Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and Tauopathy , 2006, The Journal of Neuroscience.

[17]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[18]  A. Convit,et al.  Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.

[19]  J. S. Lee,et al.  18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Armin Scheurich,et al.  Association of elevated phospho-tau levels with alzheimer-typical 18F-Fluoro-2-Deoxy-D-Glucose positron emission tomography findings in patients with mild cognitive impairment , 2004, Biological Psychiatry.

[21]  R. Nitsch,et al.  Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.

[22]  W. Kamphorst,et al.  Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients. , 2000, Human molecular genetics.

[23]  O. Haraldseth,et al.  13C MR Spectroscopy Study of Lactate as Substrate for Rat Brain , 2000, Developmental Neuroscience.

[24]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[25]  G. Frisoni,et al.  Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer’s disease: a morphometric MRI study , 2000, Biological Psychiatry.

[26]  M. Goedert,et al.  Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) , 2000, Neurogenetics.

[27]  K. Ishii,et al.  Cerebral glucose metabolism in patients with frontotemporal dementia. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[30]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[31]  F. Fonnum,et al.  Trafficking of Amino Acids between Neurons and Glia In Vivo. Effects of Inhibition of Glial Metabolism by Fluoroacetate , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  T Ernst,et al.  Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. , 1997, Radiology.

[33]  P. Cohen,et al.  Molecular dissection of the paired helical filament , 1995, Neurobiology of Aging.

[34]  F. Fonnum,et al.  Glial‐Neuronal Interactions as Studied by Cerebral Metabolism of [2‐13C]Acetate and [1‐13C]Glucose: An Ex Vivo 13C NMR Spectroscopic Study , 1995, Journal of neurochemistry.

[35]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[36]  A. Schousboe,et al.  Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons , 1993, Neurochemistry International.

[37]  J. Walker,et al.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Håberg,et al.  13C NMR Spectroscopy as a Tool in Neurobiology , 2012 .

[39]  B. Vissel,et al.  Alzheimer's disease selective vulnerability and modeling in transgenic mice. , 2009, Journal of Alzheimer's disease : JAD.

[40]  M. McLean,et al.  Approaches to studies on neuronal/glial relationships by 13C-MRS analysis. , 1996, Developmental neuroscience.